| 20.49 0.96 (4.92%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 25.94 |
1-year : | 30.29 |
| Resists | First : | 22.2 |
Second : | 25.94 |
| Pivot price | 18.99 |
|||
| Supports | First : | 19.53 |
Second : | 17.87 |
| MAs | MA(5) : | 19.29 |
MA(20) : | 19.33  |
| MA(100) : | 27.05 |
MA(250) : | 52.61 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.9 |
| %K %D | K(14,3) : | 69.5 |
D(3) : | 48.1 |
| RSI | RSI(14): 54.3 |
|||
| 52-week | High : | 108.8 | Low : | 17.87 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MED ] has closed above the upper band by 23.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 69.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 20.62 - 20.7 | 20.7 - 20.78 |
| Low: | 19.35 - 19.44 | 19.44 - 19.53 |
| Close: | 20.34 - 20.48 | 20.48 - 20.63 |
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
Thu, 25 Jul 2024
Top 20 Highest-Yielding Small Cap Dividend Stocks Now - Sure Dividend
Tue, 23 Jul 2024
Medifast (NYSE:MED) Given “Underperform” Rating at DA Davidson - Defense World
Mon, 22 Jul 2024
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024 - StockTitan
Mon, 22 Jul 2024
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024 - Business Wire
Mon, 22 Jul 2024
BNP Paribas Financial Markets Trims Stock Holdings in Medifast, Inc. (NYSE:MED) - Defense World
Sat, 06 Jul 2024
Medifast, Inc.'s (NYSE:MED) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Cyclical
|
|
|
Industry:
Personal Products & Services
|
|
| Shares Out | 11 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 2.5 (%) |
| Held by Institutions | 105 (%) |
| Shares Short | 2,940 (K) |
| Shares Short P.Month | 3,440 (K) |
| EPS | 6.19 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.72 |
| Profit Margin | 7.5 % |
| Operating Margin | 5.2 % |
| Return on Assets (ttm) | 16.4 % |
| Return on Equity (ttm) | 35.4 % |
| Qtrly Rev. Growth | -50 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 82.06 |
| EBITDA (p.s.) | 8.73 |
| Qtrly Earnings Growth | -79.4 % |
| Operating Cash Flow | 91 (M) |
| Levered Free Cash Flow | 57 (M) |
| PE Ratio | 3.31 |
| PEG Ratio | 1.2 |
| Price to Book value | 1.03 |
| Price to Sales | 0.24 |
| Price to Cash Flow | 2.46 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|